scholarly journals Denver shunt

2019 ◽  
Author(s):  
Yuranga Weerakkody ◽  
Laurent Bilodeau
Keyword(s):  
Denver Shunt

scholarly journals Symptomatic Fluid Drainage: Peritoneovenous Shunt Placement

2017 ◽  
Vol 34 (04) ◽  
pp. 343-348
Author(s):  
George Getrajdman ◽  
Hooman Yarmohammadi
Keyword(s):  
Quality Of Life ◽  
Negative Impact ◽  
Symptomatic Relief ◽  
Malignant Ascites ◽  
Indwelling Catheters ◽  
Shunt Placement ◽  
Peritoneovenous Shunt ◽  
Peritoneovenous Shunts ◽  
Denver Shunt

AbstractAscites causes significant discomfort and has negative impact on patient's quality of life. Medical therapies including dietary restriction and diuretics are successful in only 40 to 44% of patients with malignant ascites and repeated paracentesis only provides temporary symptomatic relief. Therefore, a more permanent solution is necessary. Indwelling catheters or peritoneovenous shunt placement can provide more permanent symptomatic relief and improve patients' quality of life. Unlike indwelling catheters, peritoneovenous shunts do not limit patients' life style and therefore should be offered as first option in patients who are good candidates. Denver shunt (CareFusion-BD Worldwide) is the current available peritoneovenous shunt. In this article, the indications, contraindications, technical aspects of shunt placement, and techniques to prevent postprocedure complications will be discussed.

scholarly journals A Case of Surgical Treatment Applying a Denver Shunt for Intractable Pericardial Effusion

2019 ◽  
Vol 48 (2) ◽  
pp. 125-127
Author(s):  
Sojiro Amamoto ◽  
Manabu Sato ◽  
Hiromitsu Kawasaki ◽  
Kozo Naito
Keyword(s):  
Surgical Treatment ◽  
Pericardial Effusion ◽  
Denver Shunt

Denver shunt in the treatment of refractory ascites in cirrhosis. A randomized controlled trial

1989 ◽  
Vol 9 ◽  
pp. S77 ◽  
Author(s):  
H Ring-Larsen ◽  
O Siemssen ◽  
JJ Krintel ◽  
C Stadager ◽  
JH Henriksen
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Refractory Ascites ◽  
Randomized Controlled ◽  
Denver Shunt

scholarly journals Treatment of retractory ascites -A comparison of CART, TIPS and Denver shunt-

Kanzo ◽  
2017 ◽  
Vol 58 (2) ◽  
pp. 91-96
Author(s):  
Atsushi Hirakata ◽  
Hiroshi Yoshida ◽  
Hiroshi Makino ◽  
Junji Ueda ◽  
Hideyuki Takata ◽  
...  
Keyword(s):  
Denver Shunt

Morbidity in long-term survivors after pancreatoduodenectomy for pancreatic adenocarcinoma.

2014 ◽  
Vol 32 (3_suppl) ◽  
pp. 307-307
Author(s):  
Kathryn Tzung-Kai Chen ◽  
John Parker Hoffman
Keyword(s):  
Pancreatic Adenocarcinoma ◽  
R0 Resection ◽  
Portal Veins ◽  
Clinically Significant ◽  
Portal Venous Thrombosis ◽  
Long Term Survivors ◽  
Disease Free ◽  
Denver Shunt

307 Background: Because the focus of pancreatoduodenectomy for pancreatic adenocarcinoma is placed on disease-free and overall survival, morbidity in long-term survivors is not well described. We sought to evaluate outcomes of long-term survivors of pancreatic cancer after pancreatoduodenectomy. Methods: We identified 30 patients from our prospectively collected database of patients with pancreatic adenocarcinoma who had undergone pancreatoduodenectomy, and who were without evidence of disease with at least 40 months of follow-up. Demographics, treatment and pathologic characteristics were collected for review. Data with regards to long-term sequelae were also collected, particularly those complications requiring additional procedures and the development of metachronous cancers. Results: The median length of follow up was 83 months, with 60% of patients still alive. Half the patients were male, and the median age at diagnosis was 70 years. With regard to treatment, 80% of patients received chemoradiation, with half of these patients receiving it in the neoadjuvant setting. All patients received an R0 resection, although two patients required at least partial resection of the superior mesenteric or portal veins. Thirty-three percent of patients had N1 disease. Forty-four percent of patients did not have any significant subsequent sequelae. In the remainder, four patients (13%) developed ascites requiring repeated paracentesis or Denver shunt, with median time to development (MTD) of 63 months. Six patients (20%) developed a biliary stricture requiring stent placement (MTD 56 months), one patient developed portal venous thrombosis requiring a venous stent (MTD 52 months), and 3 patients (10%) experienced clinically significant gastric anastomotic ulcers (MTD 47 months). With regards to metachronous cancers, 2 patients developed subsequent lymphomas (MTD 92 months). Conclusions: Long-term survivors of patients who undergo pancreatoduodenectomy for pancreatic adenocarcinoma can develop significant late sequelae, which often can manifest more than three to five years after surgery. Continued follow-up and counseling is warranted.

Nonsurgical Relief of Venous Limb Thrombosis in a Denver Shunt

JAMA ◽  
1984 ◽  
Vol 252 (10) ◽  
pp. 1282 ◽  
Author(s):  
Martha D. McDaniel
Keyword(s):  
Denver Shunt

scholarly journals Four Cases of Peritoneo-Venous (Denver) Shunt System for Intractable Ascites Induced by Severe Liver Cirrhosis under General Anesthesia

2010 ◽  
Vol 30 (4) ◽  
pp. 629-633
Author(s):  
Arisa HOTTA ◽  
Yohei FUJIMOTO ◽  
Naoto HORI ◽  
Kumiko HIRAKAWA ◽  
Noriko YOSHIKAWA ◽  
...  
Keyword(s):  
Liver Cirrhosis ◽  
General Anesthesia ◽  
Severe Liver ◽  
Shunt System ◽  
Intractable Ascites ◽  
Denver Shunt

Bestimmung der Count-Raten als Qualitätskontrolle bei der kombinierten Lungen-Ventilations- und Perfusionsszintigraphie: Eine Falldarstellung

1997 ◽  
Vol 36 (06) ◽  
pp. 213-217
Author(s):  
J. Heller ◽  
Ch. Scheurlen ◽  
F. Grünwald ◽  
T. Sauerbruch ◽  
H.-J. Biersack ◽  
...  
Keyword(s):  
Denver Shunt

ZusammenfassungVorgestellt wird der Fall eines 43jährigen Patienten mit einer massiven pulmonalen Embolie, ausgelöst durch thrombotische Auflagerungen einer Denver-shunt-Sonde. Bei der Lungen-Ventilations- und Perfusionsszintigraphie wurde ein zu niedriges Verhältnis zwischen den Count-raten der Ventilations- und der Perfusionsstudie festgestellt. Nach Reinjektion von zusätzlicher 99mTc-MAA-Aktivität zeigten sich in der zweiten Perfusionsstudie weitere Mismatch-Areale. Die Bestimmung der Count-Raten ist für die klinische Qualitätskontrolle essentiell.

Sign in / Sign up

Export Citation Format

Share Document